Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT
July 29, 2021 16:34 ET
|
Cellectis Inc.
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing platform company with clinical-stage immuno-oncology...
Recro Enters Development and Manufacturing Agreement With New Client
July 13, 2021 07:00 ET
|
Recro Pharma, Inc.
GAINESVILLE, Ga., July 13, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...
Monthly information on share capital and company voting rights
July 12, 2021 16:30 ET
|
Cellectis Inc.
NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
BioSpace Publishes 2021 Salary Report, Highlighting Salary Growth Despite Challenges
June 23, 2021 05:00 ET
|
BioSpace, Inc.
DES MOINES, Iowa, June 23, 2021 (GLOBE NEWSWIRE) -- BioSpace, the leader in biopharma news and careers has today published it’s 2021 U.S. Life Sciences Salary Report. The report demonstrates...
InMed Pharmaceuticals to Webcast Live at Life Sciences Investor Forum June 24th
June 22, 2021 12:29 ET
|
Life Sciences Investor Forum
VANCOUVER, British Columbia, June 22, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company developing cannabinoid-based...
NeonMind to Webcast Live at Life Sciences Investor Forum on June 24th
June 22, 2021 11:44 ET
|
Life Sciences Investor Forum
VANCOUVER, British Columbia, June 22, 2021 (GLOBE NEWSWIRE) -- NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) (“NeonMind” or the “Company”), an integrated drug development and...
NeonMind to Webcast Live at Life Sciences Investor Forum June 24th
June 22, 2021 08:35 ET
|
Life Sciences Investor Forum
VANCOUVER, British Columbia, June 22, 2021 (GLOBE NEWSWIRE) -- NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) (“NeonMind” or the “Company”), an integrated drug development and...
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021
June 21, 2021 08:35 ET
|
Life Sciences Investor Forum
NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals...
Recro Appoints Laura L. Parks, Ph.D. to Board of Directors
June 16, 2021 07:00 ET
|
Recro Pharma, Inc.
EXTON, Pa., June 16, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Monthly information on share capital and company voting rights
June 09, 2021 16:30 ET
|
Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal...